Package 42291-633-50

Brand: oxybutynin chloride extended release

Generic: oxybutynin chloride
NDC Package

Package Facts

Identity

Package NDC 42291-633-50
Digits Only 4229163350
Product NDC 42291-633
Description

500 TABLET, EXTENDED RELEASE in 1 BOTTLE (42291-633-50)

Marketing

Marketing Status
Marketed Since 2016-03-09
Brand oxybutynin chloride extended release
Generic oxybutynin chloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "46143c62-4276-2b49-e063-6294a90ae1aa", "openfda": {"upc": ["0342291635012", "0342291633018", "0342291634503", "0342291633506"], "unii": ["L9F3D9RENQ"], "rxcui": ["863619", "863628", "863636"], "spl_set_id": ["94471401-a516-0fe7-ec9c-447dd2bee972"], "manufacturer_name": ["AvKARE"]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (42291-633-01)", "package_ndc": "42291-633-01", "marketing_start_date": "20160309"}, {"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (42291-633-50)", "package_ndc": "42291-633-50", "marketing_start_date": "20160309"}], "brand_name": "Oxybutynin Chloride Extended Release", "product_id": "42291-633_46143c62-4276-2b49-e063-6294a90ae1aa", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Cholinergic Muscarinic Antagonist [EPC]", "Cholinergic Muscarinic Antagonists [MoA]"], "product_ndc": "42291-633", "generic_name": "Oxybutynin Chloride", "labeler_name": "AvKARE", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Oxybutynin Chloride", "brand_name_suffix": "Extended Release", "active_ingredients": [{"name": "OXYBUTYNIN CHLORIDE", "strength": "5 mg/1"}], "application_number": "ANDA078503", "marketing_category": "ANDA", "marketing_start_date": "20160309", "listing_expiration_date": "20261231"}